I
n the current study, Harris and colleagues [4] calculated accuracy metrics, including discrimination and calibration, for the American Joint Replacement Registry (AJRR) mortality calculator, using data from Medicare-eligible patients undergoing total joint arthroplasty (TJA) at the Veterans Health Administration (VHA).
There is a great deal of interest in predicting and managing risk in arthroplasty patients because so many of these procedures are being performed; mitigating surgical risk therefore may save both money and lives. Risk calculators can also help surgeons counsel patients about the serious complications that might occur after surgery, like death or infection. Importantly, risk-adjusted data about expected complication rates are not established for veterans or Medicare beneficiaries undergoing TJA.
Two of the authors of the original study (KJB and EL) codeveloped the risk calculator, which is based on the Medicare 5% sample claims database. It seeks to calculate the risk of periprosthetic joint infection within 2 years or mortality within 90 days of primary hip or knee replacement. Somewhat surprisingly, they found that the AJRR risk calculator predicted 90-day mortality poorly in Medicare-eligible veterans.
Risk calculators have successfully predicted the risk of revision after hip or knee arthroplasty in captive populations like Kaiser Permanente's Total Joint Replacement Registry, which contains data for hip and knee replacements performed in a large, integrated healthcare system [7] . So why didn't Harris and colleagues' attempt at external validation, which focused on Medicare-eligible veterans, work out?
The authors point out that the poor performance of the AJRR risk calculator may have resulted due to the rarity of their clinical outcomes: Mortality and infection.
Where Do We Need to Go?
The conclusions of this study support the idea that veterans undergoing arthroplasty represent a unique group of patients, and may not be comparable to the overall Medicare population, which has been suggested by others [6] . Because they served in the military, VHA patients earned their eligibility for healthcare coverage; this is different from Medicare beneficiaries, who generally become eligible for coverage on basis of their age. I believe this distinction is important because many veterans' need for arthroplasty may stem from their service and deserves the best attention to risk management. Additionally, by studying Medicare-eligible veterans, the authors may have identified a special subset of veterans who could receive care outside the VHA, but stay within the VHA system for a variety of reasons, perhaps including personal choice, other health problems, or inability to get care elsewhere based on complexity of their case. Future studies on risk calculation for veterans may be more accurate if they are based on veterans who have undergone arthroplasty within the VHA. Thus, patient counseling on their risks of complications after arthroplasty may be possible in this unique population.
Risk estimation is important because some complications are publicly reportable. Outside the VHA, alternative payment methods such as bundled payments discourage institutions from providing access to arthroplasty for high-risk patients. Such disincentives to accept risk are not appropriate in the VHA population, where the patient's diagnosis of arthritis may be service-connected. However, there is little evidence about predictive models for short-term complications after arthroplasty in VHA patients [3] . Managing risk and quality may inadvertently place highrisk patients, their surgeons, and hospitals in jeopardy with respect to quality reporting and financials.
Therefore, we need to consider the implications of calculating risk because it may affect access to care. As we move forward, setting risk adjustment when institutions report complications such as mortality or infection after arthroplasty may be more reflective of performance.
How Do We Get There?
To understand the unique needs of arthroplasty patients within the VHA, models focusing on perioperative complications after arthroplasty in veterans may be more successful. To reach this goal, a study similar to the investigation by Harris and colleagues [4] may be more successful if it were based on underlying data points from the Veterans Affairs Surgery Quality Improvement Program or a multicenter study within the VHA [4] .
In order for risk calculation to be helpful for veterans undergoing arthroplasty, an approach that allows surgeons to minimize risk while still providing access to complex patients is needed. Such an approach would likely involve identifying high-risk patients with a validated risk-adjusted calculator and then mitigating modifiable risk factors, including but not limited to, obesity, homelessness, and diabetes [1, 2, 5] .
